Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

734
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
734
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.0K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

200
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
200
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

502
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
502
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

588
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
588
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

155
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
155

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinal Pigment Epithelial Changes in Gordon Holmes Syndrome.

Journal of vitreoretinal diseases·2026
Same author

Patient-reported Vision Quality-of-life in Parkinsonian Syndromes and Ataxias and Association with Clinical Oculomotor Findings.

medRxiv : the preprint server for health sciences·2026
Same author

Functional Connectivity Predictors and Mechanisms of Symptom Change in Functional Neurological Disorder.

medRxiv : the preprint server for health sciences·2026
Same author

Correction: The Natural History Study and Biomarker Collection of the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA).

Cerebellum (London, England)·2025
Same author

Functional Connectivity Gradients Reveal Altered Hierarchical Cortical Organization in Functional Neurological Disorder.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2025
Same author

A Digital Measure of Eye Movements During Reading Sensitively Captures Oculomotor and Speech Dysfunction, Early Changes, and Disease Progression in Ataxias.

Annals of neurology·2025

Related Experiment Video

Updated: Aug 26, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.5K

The Dystonias.

Christopher D Stephen

    Continuum (Minneapolis, Minn.)
    |October 12, 2022
    PubMed
    Summary

    Recent findings enhance the diagnosis and classification of dystonia, a complex neurological movement disorder. New genetic insights and a revised classification system aim to improve recognition and management of this challenging condition.

    Area of Science:

    • Neurology
    • Genetics
    • Movement Disorders

    Background:

    • Dystonia is a complex neurological movement disorder characterized by abnormal postures.
    • It presents with diverse phenotypes, including genetic, idiopathic, and acquired forms.
    • Accurate diagnosis is challenging due to its varied presentation and potential co-occurrence with other neurological conditions.

    Purpose of the Study:

    • To review recent advancements in the diagnosis, classification, and management of dystonia.
    • To highlight a novel classification approach aimed at improving dystonia recognition.
    • To discuss the role of molecular biology and genetic studies in understanding dystonia.

    Main Methods:

    • Review of current literature on dystonia diagnosis and classification.

    More Related Videos

    Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
    10:05

    Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

    Published on: January 27, 2018

    9.8K
    Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons
    09:51

    Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons

    Published on: January 29, 2015

    16.4K

    Related Experiment Videos

    Last Updated: Aug 26, 2025

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
    10:41

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

    Published on: September 12, 2020

    7.5K
    Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
    10:05

    Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

    Published on: January 27, 2018

    9.8K
    Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons
    09:51

    Rapid Genotyping of Animals Followed by Establishing Primary Cultures of Brain Neurons

    Published on: January 29, 2015

    16.4K
  • Analysis of recent genetic and molecular findings.
  • Synthesis of information on management strategies, including pharmacological and surgical interventions.

    • Main Results:

    • A new classification system for dystonia has been developed to enhance diagnostic accuracy.
    • Identification of specific genes and biological pathways implicated in dystonia pathophysiology.
    • Established management strategies include botulinum toxin, oral medications, deep brain stimulation, and emerging gene therapies.

    Conclusions:

    • Improved classification and genetic understanding are crucial for advancing dystonia care.
    • Multifaceted management approaches are essential for addressing the diverse spectrum of dystonia.
    • Future research holds promise for disease-modifying and gene therapies for dystonia.